Welcome to our dedicated page for Evolent Health news (Ticker: EVH), a resource for investors and traders seeking the latest updates and insights on Evolent Health stock.
Evolent Health, Inc. (NYSE: EVH) plays a pivotal role in the healthcare sector by supporting health systems and physician organizations in their transition to value-based care and population health management. Headquartered in Arlington, Virginia, Evolent is backed by major entities such as The Advisory Board Company, University of Pittsburgh Medical Center Health Plan, and TPG Growth. The company’s core business revolves around providing integrated specialty care management services, total cost of care management, and health plan administration through an all-inclusive platform.
Evolent specializes in managing complex conditions in fields such as oncology, cardiology, and musculoskeletal markets, aiming to simplify healthcare and make it more affordable. The company's recent achievements include exceeding profitability expectations in the third quarter of 2023, adding new operating partnerships, and enhancing its financial outlook for the year. Evolent reported robust financial health with $184.5 million in cash and cash equivalents as of September 30, 2023.
The company’s culture is centered around collaboration, innovation, and a supportive work environment. Benefits like treadmill desks, healthy snacks, and wellness challenges underscore its commitment to employee well-being.
Notably, Evolent is also venturing into AI-driven healthcare solutions, as evidenced by its recent agreement to acquire Machinify Auth, a software platform that enhances clinical quality through advanced AI. This acquisition is expected to significantly improve the speed and efficiency of clinical reviews for various conditions.
In summary, Evolent Health continues to be a significant player in the healthcare industry, driving better health outcomes and financial performance through innovative solutions.
Evolent Health, Inc. (NYSE: EVH) announced participation in upcoming investor conferences by CEO Seth Blackley and CFO John Johnson. They will present at the Morgan Stanley 19th Annual Global Healthcare Conference on September 10, 2021, at 3:30 p.m. ET, with a live webcast available on Evolent's website. Additionally, they will present at the 2021 Cantor Global Healthcare Conference on September 27, 2021, at 9:20 a.m. ET. Evolent is known for delivering clinical and administrative solutions that improve health care efficiency and affordability.
Evolent Health, Inc. (NYSE: EVH) announced its acquisition of Vital Decisions from WindRose Health Investors for $85 million, with potential earn-outs up to $45 million. This strategic acquisition aims to integrate Vital Decisions' technology-enabled advance care planning services into Evolent's Clinical Solutions segment, enhancing patient engagement and care alignment. The deal is expected to provide significant clinical and financial synergies while being accretive to EBITDA per share. The transaction is projected to close later this year, pending regulatory approvals.
Evolent Health, Inc. (NYSE: EVH) reported financial results for Q2 2021, achieving GAAP revenue of $222.1 million, a 2.2% increase year-over-year. Organic revenue growth was notably high at 42.3%. However, the company recorded a net loss of $(9.1) million. Adjusted EBITDA rose to $13.3 million, up $2.8 million from Q2 2020. Evolent announced key acquisitions and partnerships that reflect a strategic push for growth, including the acquisition of Vital Decisions. The company also raised its full-year revenue guidance to $870-$900 million.
Evolent Health (NYSE: EVH) will have CEO Seth Blackley and CFO John Johnson present at the Canaccord Genuity 41st Annual Growth Conference on August 12, 2021, at 12:00 p.m. ET. A live webcast of the event will be available on Evolent's investor relations website. Evolent Health specializes in delivering clinical and administrative solutions to enhance healthcare affordability and manage total costs. The company has received the Population Health Program Accreditation and is recognized as a leader in healthcare service delivery.
Evolent Health (NYSE: EVH) will announce its second quarter 2021 operating results on August 4, 2021, after the market closes. A conference call will take place at 6:00 p.m. Eastern Time the same day, allowing shareholders to participate via phone. Evolent Health specializes in clinical and administrative healthcare solutions aimed at improving total care management. The company has achieved notable accreditations and is recognized for its workplace culture.
Evolent Health (NYSE: EVH) has announced that CEO Seth Blackley and CFO John Johnson will participate in the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8, 2021, at 5:30 p.m. ET. The event will feature a live webcast available on Evolent's investor relations website. Evolent Health provides clinical and administrative solutions aimed at improving health care affordability and simplicity for payers and providers, serving a national client base and recognized for its quality and workplace culture.
Evolent Health, Inc. (EVH) reported Q1 2021 GAAP revenue of $215.1 million, down from $221.2 million in Q1 2020. The net loss attributable to shareholders improved significantly to $(9.8 million), compared to $(78.8 million) in the prior year. Adjusted EBITDA was $14.9 million, a notable increase from $3.9 million in Q1 2020. With approximately 11.6 million lives managed, the company announced new partnerships aimed at expanding services in oncology and cardiology. CEO Seth Blackley emphasized strong demand for their solutions and targeted mid-teens organic growth.
Evolent Health, Inc. (EVH) reported a GAAP revenue of $215.1 million for Q1 2021, marking a decrease from $221.2 million in Q1 2020. The company achieved an Adjusted EBITDA of $14.9 million, up from $3.9 million year-on-year. A net loss attributable to shareholders was $(9.8) million, an improvement from $(78.8) million in 2020. Evolent is managing approximately 11.6 million lives and has announced new partnerships to enhance its service offerings. CEO Seth Blackley expressed optimism about the company's trajectory towards organic growth and margin expansion.
Evolent Health, listed on NYSE as EVH, announced its participation in the 2021 Bank of America Health Care Conference. Scheduled for May 13, 2021, at 2:00 p.m. ET, CEO Seth Blackley and CFO John Johnson will present. Investors can access a live webcast on the company's investor relations page. Evolent Health specializes in clinical and administrative solutions aimed at improving health care efficiency and affordability, serving a diverse range of payers and providers nationally.
FAQ
What is the current stock price of Evolent Health (EVH)?
What is the market cap of Evolent Health (EVH)?
What is the primary business of Evolent Health, Inc.?
Where is Evolent Health headquartered?
What recent financial achievements has Evolent Health reported?
What are some of the core services provided by Evolent Health?
What recent acquisition did Evolent Health announce?
Who are some of the backers of Evolent Health?
What are the primary specialty care areas Evolent focuses on?
How does Evolent Health view its company culture?
What is the significance of Evolent’s acquisition of Machinify Auth?
How has Evolent Health performed financially in recent quarters?
